High-throughput sequencing of circulating miRNAs in human reveals novel biomarkers for drug-induced liver injury, hepatitis B, liver cirrhosis and type 2 diabetes. (16th September 2016) - Krauskopf, J.; Caiment, F.; De Kok, T.M.; Johnson, K.J.; Warner, R.L.; Schomaker, S.J.; Chandler, P.; Aubrecht, J.; Kleinjans, J.C.